| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.38 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.37 | 0.07 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.07 |